Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) rose 4.5% during trading on Tuesday . The company traded as high as $1.84 and last traded at $1.84. Approximately 162,971 shares were traded during mid-day trading, an increase of 143% from the average daily volume of 67,097 shares. The stock had previously closed at $1.76.
Cardiol Therapeutics Price Performance
The business’s 50-day moving average is $1.70 and its two-hundred day moving average is $1.20.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Read More
- Five stocks we like better than Cardiol Therapeutics
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Hasbro’s Management Made All the Right Calls This Quarter
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What is a buyback in stocks? A comprehensive guide for investors
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
